FOXA2-targeted organ-selective nanotherapy for prostate cancer visceral metastasis
Research Grant
Administered By
Pathology
Awarded By
Mike Slive Foundation
Start Date
January 1, 2022
End Date
December 31, 2022
Administered By
Pathology
Awarded By
Mike Slive Foundation
Start Date
January 1, 2022
End Date
December 31, 2022